CD44 and breast carcinoma: Interestingly, Hyaluronic acid has a strong affinity for the CD44 and hyaluronan-mediated motility (RHAMM) receptors, which are overexpressed by breast cancer cells, resulting in a strong targeted capacity for tumor cells [67].